Health Trials

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

ConditionMetastatic Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.

Eligibility criteria

Qualifiers

Patients with HR+/HER2 negative MBC

On first- or second-line treatment

Life expectancy at least 12 months

Only females

Disqualifiers

Another primary cancer diagnosis within past 5 years (not including non-melanoma skin cancers)

Any major thought disorder (e.g., schizophrenia, dementia)

Communication barriers (e.g., hard of hearing)

Poorly-controlled or uncontrolled diabetes in the opinion of the physician(s)

Trial design

Treatments tested in this trial

  • Demographics/Lifestyle Survey

Treatment groups

100 Participants
are divided into 3 treatment groups

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov